- Revenue grew to $725.4M compared to $479.5M in Q3 prior year
- GAAP net loss of $(23.6M) or $(0.21) per share
- Medical Expense ratio spiked to 93.0% vs 85.0% YoY, driving Adjusted EBITDA margin down to 4.7% from 8.1%
Bearish AI Sentiment (-4.0 / 10)
Signal #144226 · SEC 8-K
$EVH SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $EVH filing catalyst
Why did $EVH trigger an AI stock catalyst alert?
$EVH triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -4.0/10). Headline: Evolent Health Q3 2026: Revenue rises to $725M but Medical Costs surge to 93%. Key points: - Revenue grew to $725.4M compared to $479.5M in Q3 prior year - GAAP net loss of $(23.6M) or $(0.21) per share - Medical Expense ratio spiked to 93.0% vs 85.0% YoY, driving Adjusted EBITDA margin down to 4.7% from 8.1%
How did $EVH stock react after the SEC filing?
After the SEC 8-K for $EVH, observed market reaction: T0 price $4.80. Past moves do not guarantee future results.
Where can I get real-time $EVH SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $EVH via Telegram and the VIP Web Terminal from €10/month.